col blocks we are bridge builder col blocks
COVID answers in Scientific Journals all over the world

Elsevier: American Heart Journal
  original article Date Title Authors   All Authors
1 [GO] 2022―Jan―02 Rationale and design of a study to assess the safety and efficacy of rNAPc2 in COVID-19: the Phase 2b ASPEN-COVID-19 trial Connie N. Hess, Warren H. Capell, Michael R. Bristow, Wolfram Ruf, Michael Szarek, David A. Morrow, et al. (+5)
2 [GO] 2021―Dec―10 Trends of Blood Pressure Control in the U.S. During the COVID-19 Pandemic Nishant P. Shah, Robert M. Clare, Karen Chiswell, Ann Marie Navar, Bimal R. Shah, Eric D. Peterson
3 [GO] 2021―Oct―30 High Glucose Variability Increases Mortality Risk in Patients with COVID-19 Arauz Guillermo, Camey Eduardo, Cárcamo Alejandra, Celis Grecia
4 [GO] 2021―Oct―30 A Pilot Open-label Study of Aldose Reductase Inhibition with AT-001 (caficrestat) in Patients Hospitalized for COVID-19 Infection: Results from a Registry-based Matched-control Analysis Juan Gaztanaga, Ravichandran Ramasamy, Ann Marie Schmidt, Glenn Fishman, Shoshana Shendelman, Karthinathan Thangavelu, et al. (+2)
5 [GO] 2021―Oct―30 The Phenomenon of Metformin in COVID-19 Pandemic Among Polish Patients with Type 2 Diabetes Mellitus Beata Mrozikiewicz-Rakowska, Daniel Bałut, Patrycja Małgorzata Bąk, Marcin Kleibert, Jakub Zieliński
6 [GO] 2021―Oct―30 QTc Prolongation in SARS-CoV-2 (COVID-19) Patients Receiving Hydroxycloroquine: A Retrospective Study M. Vlachopoylou, E.M. Hamissa, S.A. AbdAlgaffar, G. Chatzis
7 [GO] 2021―Oct―30 COVID-19 prevention with subcutaneous administration of the monoclonal antibodies casirivimab and imdevimab: Subgroup analysis in participants with cardiovascular disease and diabetes Meagan P. O'Brien, Eduardo Forleo-Neto, Bret J. Musser, Flonza Isa, Kuo-Chen Chan, Neena Sarkar, et al. (+28)
8 [GO] 2021―Oct―30 Is dyslipidemia associated to mortality in patients with COVID-19? Celis Grecia, Arauz Guillermo, Camey Eduardo, Cárcamo Alejandra
9 [GO] 2021―Oct―30 Evaluation of Cardiovascular Diseases and Diabetes Mellitus as Predisposing Factors for Mortality in Patients with Coronavirus Disease 2019: Systematic Review and Meta-Analysis Vityala Yethindra, Tugolbai Tagaev, Altynai Zhumabekova, Begaiym Begalieva, Alina Kurmanalieva, Aiganysh Umetova, et al. (+2)
10 [GO] 2021―Sep―21 The COVID-19 Pandemic and Cardiovascular Issues in Clinical Trials: Practical and Regulatory Issues in Remote Monitoring of Cardiac Safety Elektra J. Papadopoulos, Kenneth Martin Stein, Polina Voloshko, Jonathan Seltzer, Fortunato Senatore, Lt Stephen Browing, Ken Faulkner
11 [GO] 2021―Sep―01 Medically Ill hospitalized Patients for COVID-19 THrombosis Extended ProphyLaxis with rivaroxaban ThErapy: Rationale and Design of the MICHELLE Trial Eduardo Ramacciotti, Leandro Barile Agati, Daniela Calderaro, Giuliano Giova Volpiani, Caroline Candida Carvalho de Oliveira, Valéria Cristina Resende Aguiar, et al. (+20)
12 [GO] 2021―Aug―13 Cardiac Pathology 6 Months after Hospitalization for COVID-19 and Association with the Acute Disease Severity Peder L. Myhre, Siri L. Heck, Julia B. Skranes, Christian Prebensen, Christine M. Jonassen, Trygve Berge, et al. (+9)
13 [GO] 2021―Jul―22 Implementation of a Practice Plan for the Outpatient Cardiac Evaluation of Children after Acute SARS-CoV-2 Infection and a Report of Outcomes Andrew L. Dailey-Schwartz, Jameson A. Dyal, William T. Mahle, Matthew E. Oster
14 [GO] 2021―Jul―15 Admission Rates During a Second COVID-19 Lockdown Daniel Mølager Christensen, Jawad Haider Butt, Emil Fosbøl, Lars Køber, Christian Torp-Pedersen, Gunnar Gislason, Matthew Phelps
15 [GO] 2021―Jun―26 Cardiovascular Procedural Deferral and Outcomes over COVID-19 Pandemic Phases: A Multi-Center Study Celina M. Yong, Kateri J. Spinelli, Shih Ting Chiu, Brandon Jones, Brian Penny, Santosh Gummidipundi, et al. (+5)
16 [GO] 2021―Jun―12 Renin-Angiotensin-Aldosterone System Inhibitors and SARS-CoV-2 Infection: An Analysis from the Veteran's Affairs Healthcare System Alexander T Sandhu, Shun Kohsaka, Shoutzu Lin, Christopher Y Woo, Mary K. Goldstein, Paul A Heidenreich
17 [GO] 2021―Apr―21 Randomized Clinical Trial to Evaluate a Routine Full Anticoagulation Strategy in Patients with Coronavirus Infection (SARS-CoV2) Admitted to Hospital: Rationale and Design of the ACTION (AntiCoagulaTlon cOroNavirus)-Coalition IV Trial Renato D. Lopes, Pedro Gabriel Melo de Barros e Silva, Remo H.M. Furtado, Ariane Vieira Scarlatelli Macedo, Eduardo Ramacciotti, Lucas Petri Damini, et al. (+11)
18 [GO] 2021―Apr―15 Renin-Angiotensin system inhibitors effect before and during hospitalization in COVID-19 outcomes: final analysis of the international HOPE COVID-19 (Health Outcome Predictive Evaluation for COVID-19) Registry. Iván J. Núñez-Gil, Iván Olier, Gisela Feltes, María C Viana-Llamas, Charbel Maroun-Eid, Rodolfo Romero, et al. (+25)
19 [GO] 2021―Mar―19 Venous Thromboembolism Among Patients Hospitalized with COVID-19 at Veterans Health Administration Hospitals J. Antonio Gutierrez, Marc D. Samsky, Ryan D. Schulteis, Lin Gu, Rajesh V. Swaminathan, Aaron W. Aday, Sunil V. Rao
20 [GO] 2021―Feb―09 Rationale and Design for the Study of Rivaroxaban to Reduce Thrombotic Events, Hospitalization and Death in Outpatients with COVID-19: the PREVENT-HD Study Warren H. Capell, Elliot S. Barnathan, Gregory Piazza, Alex C. Spyropoulos, Judith Hsia, Scott Bull, et al. (+6)
21 [GO] 2020―Nov―26 Cardiac intensive care unit during the coronavirus disease 2019 surge Boban Thomas, Imad Hassan
22 [GO] 2020―Nov―10 Thrombosis in Hospitalized Patients with Viral Respiratory Infections versus COVID-19 Nathaniel R. Smilowitz, Varun Subashchandran, Eugene Yuriditsky, James M. Horowitz, Harmony R. Reynolds, Judith S. Hochman, Jeffrey S. Berger
23 [GO] 2020―Nov―06 Incidence of acute coronary syndrome during national lock-down: insights from nationwide data during the coronavirus disease 2019 (COVID-19) pandemic Lauge Østergaard, Jawad Haider Butt, Kristian Kragholm, Morten Schou, Matthew Phelps, Rikke Sørensen, et al. (+5)
24 [GO] 2020―Nov―01 Impact of the COVID-19 Pandemic on Patterns of Outpatient Cardiovascular Care Jedrek Wosik, Megan E.B. Clowse, Robert Overton, Bhargav Adagarla, Nicoleta Economou-Zavlanos, Joanna Cavalier, et al. (+5)
25 [GO] 2020―Oct―26 Characteristics of Clinical Trials Evaluating Cardiovascular Therapies for Coronavirus Disease 2019 Registered on ClinicalTrials.gov: A Cross Sectional Analysis Anubodh S. Varshney, David E. Wang, Ankeet S. Bhatt, Alexander Blood, Musa A. Sharkawi, Hasan K. Siddiqi, et al. (+8)
26 [GO] 2020―Sep―30 Internet search volume for chest pain during the COVID-19 pandemic Jonathan L Ciofani, Daniel Han, Usaid K Allahwala, Kaleab N Asrress, Ravinay Bhindi
27 [GO] 2020―Aug―12 Telemedicine in myocarditis: Evolution of a mutidisciplinary “disease Unit” at the time of COVID-19 pandemic Giovanni Peretto, Giacomo De Luca, Corrado Campochiaro, Anna Palmisano, Elena Busnardo, Silvia Sartorelli, et al. (+4)
28 [GO] 2020―Jul―03 The cardiac intensive care unit and the cardiac Intensivist during the COVID-19 surge in New York City D. Edmund Anstey, Raymond Givens, Kevin Clerkin, Justin Fried, Nellie Kalcheva, Deepa Kumaraiah, et al. (+10)
29 [GO] 2020―Jun―16 COVID-19 and the cardiovascular system: A review of current data, summary of best practices, outline of controversies and illustrative case reports Anand Prasad, Siyab Panhwar, Robert C. Hendel, Omar Sheikh, Zunair Mushtaq, Fatima Dollar, et al. (+12)
30 [GO] 2020―May―23 Decrease in acute coronary syndrome presentations during the COVID19 pandemic in upstate New York Nabil Braiteh, Wajeeh ur Rehman, Md Alom, Vincent Skovira, Nour Breiteh, Ibraheem Rehman, et al. (+3)
31 [GO] 2020―May―21 Rationale and design of the PRAETORIAN-COVID trial: A double-blind, placebo-controlled randomized clinical trial with valsartan for PRevention of Acute rEspiraTORy dIstress syndrome in hospitAlized patieNts with SARS-COV-2 Infection Disease D.H. Frank Gommans, Joris Nas, Sara-Joan Pinto-Sietsma, Yvonne Koop, Regina E. Konst, Frans Mensink, et al. (+32)
32 [GO] 2020―May―15 Cardiovascular comorbidities, cardiac injury and prognosis of COVID-19 in New York City Toshiki Kuno, Mai Takahashi, Reiichiro Obata, Tetsuro Maeda
33 [GO] 2020―May―13 Continuing versus suspending angiotensin-converting enzyme inhibitors and angiotensin receptor blockers: Impact on adverse outcomes in hospitalized patients with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) Renato D. Lopes, Ariane Vieira Scarlatelli Macedo, Pedro Gabriel Melo de Barros e Silva, Renata Junqueira Moll-Bernardes, Andre Feldman, Guilherme D'Andréa Saba Arruda, et al. (+9)
34 [GO] 2020―May―11 Impact of COVID-19 pandemic on patients with ST-segment elevation myocardial infarction: Insights from a British cardiac center Hesham K Abdelaziz, Amr Abdelrahman, Amjad Nabi, Maciej Debski, Amgad Mentias, Tawfiq Choudhury, et al. (+2)
35 [GO] 2020―May―08 Covid-19 pandemic-some cardiovascular considerations from the trench Bernardo Cortese
36 [GO] 2020―May―06 Impact of COVID-19 epidemic on coronary care unit accesses for acute coronary syndrome in Veneto region, Italy Folino Franco, Zorzi Alessandro, Cernetti Carlo, Marchese Domenico, Pasquetto Giampaolo, Roncon Loris, et al. (+7)
37 [GO] 2020―May―03 Anticipating and curtailing the Cardiometabolic toxicity of social isolation and emotional stress in the time of COVID-19 Ohad Oren, Bernard J. Gersh, Roger S. Blumenthal
38 [GO] 2020―May―03 A current review of COVID-19 for the cardiovascular specialist Joshua P. Lang, Xiaowen Wang, Filipe A. Moura, Hasan K. Siddiqi, David A. Morrow, Erin A. Bohula
39 [GO] 2020―May―03 A care pathway for the cardiovascular complications of COVID-19: Insights from an institutional response Rahul S. Loungani, Michael R. Rehorn, L. Kristin Newby, Jason N. Katz, Igor Klem, Robert J. Mentz, et al. (+6)


[de][en]

Last change 2022―Jan―20 20:43:25 UTC

© Daten-Quadrat 2022       Done in 0.005 sec